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Abstract
Background: A mathematical model was designed to explore the impact of three strategies for
better tuberculosis case finding. Strategies included: (1) reducing the number of tuberculosis
patients who do not seek care; (2) reducing diagnostic delay; and (3) engaging non-DOTS providers
in the referral of tuberculosis suspects to DOTS services in the Indonesian health system context.
The impact of these strategies on tuberculosis mortality and treatment outcome was estimated
using a mathematical model of the Indonesian health system.
Methods: The model consists of multiple compartments representing logical movement of a
respiratory symptomatic (tuberculosis suspect) through the health system, including patient- and
health system delays. Main outputs of the model are tuberculosis death rate and treatment
outcome (i.e. full or partial cure). We quantified the model parameters for the Jogjakarta province
context, using a two round Delphi survey with five Indonesian tuberculosis experts.
Results:  The model validation shows that four critical model outputs (average duration of
symptom onset to treatment, detection rate, cure rate, and death rate) were reasonably close to
existing available data, erring towards more optimistic outcomes than are actually reported. The
model predicted that an intervention to reduce the proportion of tuberculosis patients who never
seek care would have the biggest impact on tuberculosis death prevention, while an intervention
resulting in more referrals of tuberculosis suspects to DOTS facilities would yield higher cure rates.
This finding is similar for situations where the alternative sector is a more important health
resource, such as in most other parts of Indonesia.
Conclusion: We used mathematical modeling to explore the impact of Indonesian health system
interventions on tuberculosis treatment outcome and deaths. Because detailed data were not
available regarding the current Indonesian population, we relied on expert opinion to quantify the
parameters. The fact that the model output showed similar results to epidemiological data suggests
that the experts had an accurate understanding of this subject, thereby reassuring the quality of our
predictions. The model highlighted the potential effectiveness of active case finding of tuberculosis
patients with limited access to DOTS facilities in the developing country setting.
Published: 8 June 2009
BMC Infectious Diseases 2009, 9:87 doi:10.1186/1471-2334-9-87
Received: 15 September 2008
Accepted: 8 June 2009
This article is available from: http://www.biomedcentral.com/1471-2334/9/87
© 2009 Ahmad et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
Page 2 of 10
(page number not for citation purposes)
Background
Tuberculosis (TB) is one of the world's leading causes of
death and disease. Despite the development and availability
of effective treatment for several decades, TB still results in
1.6 million deaths per year [1]. Reducing the burden of glo-
bal TB disease is a part of broader developmental frame-
works such as the Millennium Development Goals (MDG).
The MDG clearly state that prevalence and mortality rate of
TB should be addressed with a goal towards increase in case
detection rate (CDR) and treatment success rate within
DOTS (Direct Observed Treatment, Short course) strategy.
The importance of intensified case finding was acknowl-
edged by the Second Ad Hoc Committee on the Tuberculosis
Epidemic, who recognized that DOTS alone was incapable
of reducing morbidity and mortality in TB patients [2].
Indonesia is ranked third in the world for tuberculosis
burden [1]. Following the nation-wide introduction of
DOTS in 1995, the country's National TB Control Pro-
gram (NTP) has successfully reached the international tar-
gets for case detection (> 70%) and treatment success (>
85%) [1]. However, much work remains to be done to
ensure these achievements contribute to the TB-related
MDG of cutting the prevalence and death rate in half by
2015. The Stop TB Partnership has recommended a six-
point strategy to reach these goals. The strategy compo-
nents are: (1) quality DOTS expansion and enhancement;
(2) addressing TB/HIV, multi-drug resistant TB (MDR-
TB), and other challenges; (3) health system strengthen-
ing; (4) broader engagement of all care providers; (5)
empowering communities; and (6) promoting research
[3]. This recommendation addresses the importance of
intensified efforts towards case finding. The Indonesian
NTP has accordingly adopted this strategy into its 2006–
2010 strategic framework [4]. Thus the current challenge
for the NTP is determining how to best allocate limited
resources across the six-point strategy. Clearly, with lim-
ited resources, there is a need to rationally set priorities.
In an effort to determine the most efficacious method of case
finding, we developed a mathematical model of the health
system through which TB patients seek care. We explored the
potential use of this model to optimize TB case finding in the
Indonesian health system context, by comparing three possi-
ble case finding intervention strategies: (1) reducing the
number of TB patients who do not seek care; (2) reducing
patients' delay in seeking treatment; and (3) engaging non-
DOTS providers in the referral of TB suspects to DOTS serv-
ices. Applying an innovative method, the parameters in the
model are quantified by an adjusted Delphi approach using
expert knowledge.
Methods
Model structure
We developed a compartmental model that describes a TB
patients' care seeking behavior and the health system per-
formance of both DOTS and non-DOTS services (e.g. pri-
vate physicians, nurses, and midwives) in Indonesia. The
model was developed with ModelMaker™ version 3.0.3.
The model mimics the journey of pulmonary TB patients
beginning with the onset of symptoms and follows their
care seeking behavior through the health system (Figure
1). Our model population is applicable to all sympto-
matic TB cases; all smear positive patients, and a subpop-
ulation of smear negative patients with symptoms serious
enough to potentially prompt them to seek health care.
There are 11 compartments within the model. Each com-
partment represents a situation that TB patients encounter
during care seeking after the onset of TB clinical symp-
toms. The model begins with symptomatic TB patients in
the population not yet seeking health care (Not seeking
care). A proportion of TB patients will never be identified
because they never seek help (Never seeking), or prema-
turely drop out of the health care system before being
identified as a TB case. However, the majority of patients
will eventually be diagnosed and cured after proper chem-
otherapy.
TB patients may choose three different types of health care
providers:Alternative, Non-DOTS, and DOTS services; how-
ever, adequate (not necessarily standardized) infrastructure
for TB diagnosis and treatment can only be accessed
through DOTS and Non-DOTS service providers. The Alter-
native services concern all health providers that do not prac-
tice modern western medicine, such as traditional healers
and spiritualist. Alternative services also include self-medica-
tion, both using traditional or modern (over the counter)
medicine. We assume that patients can move directly from
the Alternative services to either DOTS or Non-DOTS services,
while patients in DOTS or Non-DOTS services need to move
back to Not seeking care before possibly moving to another
sector. If patients do not drop out, they will eventually be
identified as TB suspects and referred for diagnostic testing
(DOTS lab1 or Non-DOTS lab1).
Several potential outcomes may result from the diagnostic
process. Following diagnostic testing, patients may be (i)
identified as TB positive (i.e. true positive diagnosis) and
referred for treatment (DOTS treatment and Non-DOTS
treatment), (ii) identified as TB negative (i.e. false negative
diagnosis) but require additional testing, or (iii) identi-
fied as TB negative with a move back to the Not seeking care
compartment, i.e. drop-out. TB patients who are referred
for a second diagnostic test (DOTS lab2 and Non-DOTS
lab2) may follow one of the following courses: (i) diag-
nosed as TB positive and recommended for treatment, (ii)
diagnosed as TB negative and exit the health system, or
(iii) fail to complete testing and drop out of the system.
The two final compartments, DOTS treatment and Non-
DOTS treatment are stages where TB patients receive treat-BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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ment. Some of the referred patients will not receive treat-
ment and drop out of the system. However most patients
will be cured or partially cured. Partially cured means TB
patients have received treatment for some period of time,
but have failed to complete the full course of therapy; thus
they are at risk of relapse.
Durations and proportions are parameters of the model that
may vary based on strategic intervention or changes in patient
behavior. Durations are defined as the average full duration of
being in certain compartment; these values do not include the
duration of patients who drop out from the compartment.
Proportions concern the fractions of TB patients moving into
the next compartments. All durations are reported in weeks.
The duration and proportions per compartment were trans-
lated into transition rates (i.e. number/week) of TB patients
moving to adjacent compartments.
Other parameters included in the model are TB death rate
and spontaneous recovery rate for TB patients not receiv-
ing treatment. Using the Berg study data from the pre-
treatment era [5], we estimated that the TB death and
recovery rate are approximately 0.3 and 0.2 per year,
respectively. These rates correspond to a cumulative TB
death and recovery of 40% and 29% after two years, or
73% and 26% after 10 years, respectively, in the absence
of effective treatment.
The main outcomes of the model are death, spontaneous
cure, and partial- or full cure after treatment. Additional
outcomes are the average duration of the care seeking
process i.e. duration before treatment, the case detection
and cure rate, and TB death rate.
Basic structure of the health system compartmental model, and corresponding parameters as quantified through expert con- sultation Figure 1
Basic structure of the health system compartmental model, and corresponding parameters as quantified 
through expert consultation. Boxes represent compartments, i.e. stages of the care seeking process. Arrows represent the 
flow (transition) of individuals between compartments. These individuals are TB suspects/respiratory symptomatics, who are 
defined as patients with pulmonary TB symptoms serious enough to trigger them to seek health care. TB diagnosis and treat-
ment is not available in the alternative health sector. In DOTS services, the first laboratory examination (DOTS lab1) is smear 
microscopy and the second examination (DOTS lab2) is chest X ray, while in Non-DOTS services the situation is vice versa. 
Parameters are durations and proportions. Durations are defined as the average full duration of being in a certain compart-
ment, thus not including dropout. Proportions concern fractions of TB patients moving into the next compartments. Main out-
comes of the model are TB death, cure, and spontaneous recovery. A; B; C are the intervention strategies simulated in this 
model (see text and Table 3). * Negative test result; ** drop out during diagnostic process. The dotted arrow represents a 
direct flow from Alternative to DOTS services.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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Parameter quantification process
Parameter quantification was conducted through a two
round modified Delphi survey. Due to the poor response
rate when using questionnaires, as suggested in the stand-
ard Delphi guideline, we instead conducted direct inter-
views with all participants. Ten experts were identified,
and five of these agreed to participate. The experts were
selected based on their experience related to the Indone-
sian TB control program and/or patients care seeking
behavior. We made appointments to meet the experts
individually for each round. During each individual
encounter we posed several questions displayed as a Word
file on a laptop computer. Responses were entered directly
into the file. We reviewed the answers with the expert
before we saved the file as their final response for that
round.
During the initial round, participants were first asked to
give their view on the basic assumptions of the model
structure, in particular the assumptions that some of the
patients never seek care, that drop-outs move back to the
Not seeking care compartment, and the specific diagnostic
process sequence. Thereafter they were asked to provide
initial estimates for all durations and proportions in the
model. In the second round, the mean, median, and
extreme responses were presented and participants were
invited to revise their estimates given the initial round
results. For our analysis we used the reported median of
proportions and durations from the second round.
The experts were asked to consider the context of Jogja-
karta province, which is located in the central part of Java
Island. The province consists of a mix of urban, semi
urban, and rural districts. It has a relatively well-estab-
lished TB control program according to Indonesian stand-
ards. It has a TB incidence of 63/100,000, which is the
lowest incidence rate in Indonesia [6]. Furthermore, sev-
eral new TB control interventions, such as public-private
hospital involvement, have been piloted in this province
with positive outcomes [7].
DOTS services in Indonesia are mainly based in public
health centers. However, current NTP policy is to involve
hospitals (both public and private) as part of the "engag-
ing all care providers" strategy. In Jogjakarta province, the
hospital DOTS linkage had been implemented for five
years and reached its maturity prior to conduction of this
study. Thus, we can safely assume that the diagnosis pro-
cedures and treatment in DOTS hospitals are to a large
extent identical to the health centers.
Model explorations and data validation
Initially, we ran the model to validate the quantifications
derived from the experts and verify that they resulted in
meaningful predictions. To this end, we used the model to
simulate a cohort of symptomatic TB patients and predict
in which compartments they would ultimately be located.
The following four typical TB program indicators were
compared with actual data: duration before treatment,
case detection rate, cure rate, and TB death rate. Duration
before treatment is the average duration of time from ini-
tial location within the Not seeking care compartment to
the point before entering the DOTS treatment compart-
ment for all symptomatic TB cases ultimately ending in
the DOTS treatment compartment. Case detection is the
proportion of a full cohort of symptomatic TB cases start-
ing in Not or Never seeking care that eventually move to
DOTS treatment via DOTS lab1. Cure rate is the proportion
of all symptomatic TB cases in the DOTS treatment com-
partment that are ultimately cured. TB death rate is the
proportion of a full cohort of symptomatic TB cases start-
ing in Not or Never seeking care that die over time due to
TB.
For model validation, we compared these four typical TB
program indicators with actual data from the national or
provincial TB program.
￿ The duration before treatment was derived from the lat-
est Indonesian TB prevalence survey in 2004 [6].
￿ In the model, case detection rate was defined as all TB
patients (smear positive and smear negative) detected in
both DOTS and Non-DOTS services. However, since the
existing information available from the Indonesian TB
program only includes smear positive TB cases detected in
DOTS services, we compared the smear positives detected
in DOTS lab1 in our model output with the proportion of
smear positive detected within the WHO estimated
number of total TB cases and the proportion of smear pos-
itive detected within the WHO estimated number of
smear positive cases. If we assume that symptomatic cases
consist of all smear positive cases and between 10%–40%
of smear negative TB cases, using the WHO estimated inci-
dence rate of all cases (239/100,000) and the estimated
smear positive incidence (108/100,000) for Indonesia
[8], the estimated incidence for all symptomatic cases is
between 121 and 160 per 100,000 population. Using the
estimated smear positive incidence for Jogjakarta province
(63/100,000) [6], this translates to an estimated incidence
of all symptomatic cases in this province of 71–94/
100,000 population. Given the population size of Jogja-
karta of 3.44 million in 2005 [9], this leads to 2,400–
3,200 symptomatic cases in Jogjakarta. Using the notified
number of 1,240 smear positive TB cases reported in Jog-
jakarta province in 2005 [9], this leads to 39% to 52% of
all symptomatic TB cases detected in the DOTS services in
Jogjakarta.
￿ The cure rate is the proportion of new smear positive TB
patients cured after treatment received within DOTS serv-
ices. The reported number of patients cured in the Jogja-BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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karta province TB program surveillance system was 1053
of a total of 1300 TB patients treated in DOTS facilities in
Jogjakarta province in 2005 [9]. This represents a cure rate
of 81%.
￿ TB observed death rate is estimated from the 2005
WHO-reported TB mortality rate of Indonesia, 41/
100,000 [8]. We adjusted this value to exclude extra-pul-
monary TB cases by assuming that the pulmonary TB
death rate is 80% of the WHO figure. Furthermore, we
assume that the Jogjakarta figure is 60% of the national
pulmonary TB death. This lower death rate is based on the
general health indicators of Jogjakarta province, which are
better than those of Indonesia as a whole. Although the
crude mortality rate is slightly higher (7.8 compared to
6.6/100,000), the life expectancy at birth and maternal
mortality rate are considerably better in Jogjakarta. More-
over, the health system performance in Jogjakarta is far
better than in Indonesia in general; TB is one of the top
ten causes of death nationally, while this was not the case
in Jogjakarta province. Based on these calculations, the
pulmonary TB death rate in Jogjakarta province should be
20/100,000. Given the population size of 3.44 million,
we arrive at approximately 700 pulmonary TB deaths in
Jogjakarta per year. This means that the 'observed' TB
death is between 22%–29% in 2005.
These model outcomes were used as the baseline situation
to be compared with three strategies to improve TB case
finding. The strategies are as follows: strategy (A) is to
reduce the proportion of TB patients who never seek care
(Never seeking care compartment) by 50%; the second
strategy (B) is to reduce patients' delay (reduce duration in
Not seeking care compartment by 50%); the third strategy
(C) is to refer all TB suspect patients from non-DOTS serv-
ices to DOTS services (i.e. from Non-DOTS services to
DOTS lab1 compartment).
We also considered a different scenario in which a greater
proportion of TB patients remain in the Alternative services
sector. In this model, we assumed that 20% of the TB
patients that would have gone to the DOTS  and Non-
DOTS compartment now move to the Alternative services
compartment. Also in this model, patients cannot move
directly from the Alternative sector to other sectors, but
first need to return to the Not seeking care compartment.
This scenario reflects the health system situation of Indo-
nesian settings outside Java-Bali, where the number of
health care facilities (both public and private) is less, and
TB patients face greater geographical challenges.
Sensitivity analysis
A univariate sensitivity analysis was performed to assess
how the main results (proportions death and partially
cured) change with different model assumptions. To this
end we multiplied the baseline values of the transition
rates of patients going out of each compartment by 2/3
and 3/2, one rate at a time, and ran the model again. The
change in outcomes gives an indication of the sensitivity
of the model to the assumed parameter values. By varying
transition rates, rather than the expert-derived propor-
tions, all proportions moving out of particular compart-
ments still add up to 100%.
Results
Parameter quantification
All experts (Table 1) agreed that the model structure and
diagnostic process sequence provided an adequate repre-
sentation of reality for TB patients and the TB control pro-
gram in Indonesia. The medians of the expert derived
average durations and proportions are reported in Figure
1. In general, the experts suggested that most of the TB
patients (90%) seek treatment, with an average duration
of 2.5 weeks after their first symptoms before entering the
healthcare system. Fifty percent of those seeking treatment
go to DOTS services and 20% to Alternative services as their
first health service preference. The experts also acknowl-
edged that DOTS services have a better capacity to diag-
nose and treat TB patients, with a lower drop out rate
during treatment and a higher cure rate, compared to non-
DOTS services. The experts reported a slightly longer dura-
tion until treatment for the Non-DOTS sector compared
to the DOTS sector. In particular, the assumed duration
prior to TB suspicion was 1.5 weeks longer, whereas this
was only partly counterbalanced by a 0.5-week shorter
duration until diagnosis by the first lab. Furthermore,
Table 1: Characteristics of the expert panel
Expert 1: TB project manager with a vast experience in developing public-private mix among hospitals (TB Hospital DOTS Linkage/HDL) in 
Jogjakarta province since 2000–2005.
Expert 2: Microbiologist who works at the university and as laboratory technical consultant for the TB control program. The expert is also 
involved in the laboratory capacity strengthening, as a part of the TB Hospital DOTS Linkage project in Jogjakarta. Member of national 
TB laboratory working group. Has recent experience with the study of TB patients' care seeking behavior in this province.
Expert 3: Urban district TB control program manager with recent experience of conducting a TB patients care seeking behavior study in 
Jogjakarta province.
Expert 4: Former rural district TB-control program manager who has health promotion expertise and vast experience in health seeking behavior 
interventions.
Expert 5: Medical doctor who was head of a public health center in Jogjakarta during the daytime and a private practitioner in the evening. As the 
head of the health center the expert has experience in involving private practitioners in the health center catchment area.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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there were no considerable differences in the experts' esti-
mated parameter values (i.e. durations and proportions)
between the first and second Delphi round (data not
shown).
Model simulation
Figure 2 shows a baseline cohort of TB patients during
their care seeking process. Most of the patients are cured
after treatment. Only a small fraction of TB patients,
mainly those who never seek treatment, remain as a
source of infection after 100 weeks (approximately 2
years). The model also demonstrates that only a negligible
proportion of TB patients stay in the Alternative services
sector, compared to the DOTS or Non-DOTS services.
It is reassuring that the Delphi survey quantifications cor-
respond with an average total duration before treatment
of 9.3 weeks. This is in agreement with findings from a
recent Indonesia national TB prevalence survey, which
reported a mean of 10.3 weeks (Table 2). Other critical
model outputs are also similar to the existing data. The
model prediction for the proportion of smear positive TB
patients through DOTS services is within the range of the
existing TB case finding data, and the predicted cure rate is
slightly less than that found in the data. However, the pre-
dicted mortality rate in the model is lower than the esti-
mated range of TB death in Jogjakarta province. As a
whole, all model predictions are reasonably close to the
reported data, but to some degree overly optimistic.
If we consider an alternative situation in which 20% of
patients move to the alternative sector, instead of to the
DOTS and Non-DOTS services, the average total duration
before treatment would be 12 weeks (not shown). Also for
this scenario, most of the TB patients are cured; however a
larger proportion of TB cases would die and the cure rate
would be lower than in the previous situation (Table 3).
Table 3 illustrates the outcomes of different possible case
finding strategies simulated in the model. Strategy A,
which is to reduce the number of TB patients who never
seek care, is more effective in preventing deaths than strat-
egy B and C. However, strategy C, involving private pro-
viders in the referral of TB patients to DOTS facility, leads
to a substantially higher proportion of fully cured patients
among those receiving treatment. These findings are sim-
ilar for the scenario with a higher rate of patients initially
entering the alternative health sector.
Figure 3 shows the results of sensitivity analysis. It is clear
that changing the model parameters has only a limited
impact on outcomes. TB death varied maximally from
15.9 to 17.2 (baseline value of 16.6), while the propor-
tion partially cured varied from 17.9 to 21.7 (baseline
value of 19.6). The transition rate from Not seeking care to
Non-DOTS services has the strongest influence on the pro-
portion partially cured. A higher flow to Non-DOTS serv-
ices  leads to more patients partially cured, and the
proportion TB death slightly decreases as well. The flow
from Not seeking care to DOTS services has by far the big-
gest influence on TB death, and illustrates that assuming a
higher rate of patients going to the DOTS services corre-
sponds with a decreased death rate. The proportion par-
tially cured decreases to a comparable degree. Dropout
rates (i.e. moving back to Not seeking care) show a modest
but consistent pattern: a higher rate of dropping out from
the non-DOTS compartments of the model always leads
to more TB death and less partially cured, whereas drop-
ping out from the DOTS compartments always leads to
both more TB death and more partially cured.
Discussion
This mathematical model guided by parameter values based
on expert opinion is a novel approach to study the role of
health systems in TB control. Findings from the model sim-
ulation suggest that some critical outputs of the model are
reasonably close to the existing data, although they tended to
be somewhat optimistic. Model explorations show that
increasing care-seeking behavior may have a considerable
impact on preventing TB death. Additionally, referral of sus-
pected TB cases to DOTS facilities will increase treatment suc-
cess and prevent partial cure. This finding is similar to a
situation with more patients initially entering the alternative
health sector. Furthermore, sensitivity analysis revealed that
the model predictions are not very sensitive to the assumed
parameter values, with the health care seeking rates having
the biggest impact.
As the TB control program relies on passive case finding,
success is determined by patients' care seeking behavior
Cumulative outcome of the care seeking process of TB  patients' cohort, starting in Not seeking care (90%) and Never  seeking care (10%) compartments Figure 2
Cumulative outcome of the care seeking process of 
TB patients' cohort, starting in Not seeking care (90%) 
and Never seeking care (10%) compartments.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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and health system performance. Previous studies examin-
ing TB case finding mainly focus on either the care-seeking
behavior of TB patients [10-14] or the health system deter-
minants [7,15-17]. In the 1970s, Piot developed a model
of the TB treatment-seeking process, which included both
patient- and health system determinants [18]. Two recent
studies [19,20] have addressed the interaction between TB
patients and health system through modeling; however
these studies focused more on the diagnostic process
rather than case finding strategies. Our study contributes
to the body of knowledge by combining all factors related
to TB control into one coherent framework using mathe-
matical modeling. This model takes into account the var-
ious types of existing health services, the duration and
pattern of care seeking behavior, and TB patient outcome
(i.e. death, partial/full cure, and spontaneous recovery).
Our model does not account for the complexities present
in the natural history of TB infection, but considers a sim-
ple constant risk of death or spontaneous recovery while
being in the health system. Including progression and
regression of the disease through different stages of sever-
ity would allow prediction of the impact of early case
detection. Relapse after treatment failure or incomplete
cure, MDR-TB, and HIV co-infection will have a different
impact on the progression and risk of death in individual
TB cases. A more complex model has been designed that
considers these factors [21]. Our model also does not
include TB transmission. In reality, earlier and better treat-
ment of TB patients will to some extent lower the trans-
mission rate and thereby result in fewer secondary cases in
the population. Our predictions on prevented TB deaths
are therefore underestimations.
It is difficult to estimate the number of TB patients existing
outside government run health services in Indonesia and
other developing countries. Consensus methods, such as
Delphi, are likely the only means to obtain quantitative
Table 2: Comparison of model output with available data
Existing data Model output
Mean duration from the first TB symptoms to treatment (weeks) 10.3a 9.3
Proportion (%) of all TB-cases detected as smear positive through DOTS services 39 – 52b 48.0
Proportion (%) of TB patients in the DOTS services eventually cured 81.0c 72.3
Proportion (%) of all TB cases that eventually die 22 – 29d 16.6
Model output and data concern symptomatic pulmonary TB cases; both smear positive and part of smear negatives, with symptoms serious enough 
to potentially prompt them to seek health care.
a based on an Indonesian TB prevalence survey in 2004 [7].
b based on smear positive cases detected in Jogjakarta province TB program, assuming that all smear positive and between 10%–40% smear negative 
TB cases are symptomatic.
c the reported cure rate from Jogjakarta provincial TB program in 2005 [9].
d based on the WHO estimated death rate for Indonesia as a whole, after correction for 20% extra-pulmonary TB and a 40% lower death rate in 
Jogjakarta Province [1].
Table 3: Predicted effect of three interventions (A, B, C) on a cohort of TB patients (%)
With intervention
Scenario Model outcome No intervention A B C
Baselinea Death 16.6 14.2 15.5 16.5
Partially cured 19.6 20.7 20.1 11.5
Cured 52.8 55.7 54.1 61.0
Spontaneous recovery 11.1 9.5 10.3 11.0
More important alternative health sectorb Death 18.1 15.8 16.6 18.0
Partially cured 18.5 19.6 19.2 11.1
Cured 51.2 54.1 53.1 58.9
Spontaneous recovery 12.1 10.5 11.1 12.0
A: strategy to reduce the proportion of TB patients who never seek care (Never seeking compartment) by 50%;
B: strategy to reduce patients' delay (i.e. reduce duration in Not seeking care compartment) by 50%;
C: strategy to refer all TB suspect patients from non-DOTS services to DOTS services (from Non-DOTS services to DOTS lab1 compartment).
a: Simulation using experts estimated parameters
b: Simulation using adjusted parameters in the alternative health sector, i.e. if 20% of the flow of TB patients to the DOTS and Non-DOTS services 
compartments now move to the Alternative services compartment (i.e. the proportion of TB patients move from Not seeking care compartment to 
Alternative, Non-DOTS, and DOTS services compartments are 36%, 24%, and 40% respectively), and patients cannot go directly to the DOTS and Non-
DOTS services.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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information [22,23]. Despite the fact that most of the Del-
phi studies are not designed to be statistically significant
and the ideal panel size has not been identified [22], most
studies involve large numbers of participants [22-26].
Therefore, our expert estimated parameters should be
interpreted with caution. Still, our results show that the
critical outcomes of our model are reasonably close to the
existing data, which supports the validity of the parame-
ters (Table 2). It is notable that outcomes of our model are
consistently – but to different degrees – more optimistic
than epidemiological data. We realize that we could not
do a formal statistical validation of the model, since the
'observed' data themselves are partly based on model pre-
dictions (by WHO) and additional assumptions.
Because health system characteristics and TB patients' care
seeking behavior differs in different regions, our study
results may not be directly generalizable to other settings.
However, the model can be adapted to others settings pro-
vided parameter values are regionally specific.
At present, there is a recognized global urgency to improve
TB case detection [27]. The Second Ad Hoc Committee on
the Tuberculosis Epidemic also acknowledged that a high
DOTS treatment rate alone was incapable of reducing
morbidity and mortality, without additional intensified
case finding [2]. Heller et al. used modeling simulation
and suggested a similar result [28]. There are several differ-
ent strategies for increasing case finding, such as active
case finding (ACF), enhanced case finding (ECF) [29], and
expanded passive case finding via increased interaction
with private sectors [30]. The difference between ACF and
ECF is the level of direct interaction with the target popu-
lation. ACF is often more labor intensive, involving face-
to-face contact and immediate onsite evaluation. ECF
educates the population about the symptoms of TB
through publicity and education, and encourages self-
presentation to medical services [29]. Studies also show
that implementation strategies of ACF (radiography
screening or symptom based screening [31], tuberculin
screening [32], and contact tracing [33-35]), ECF (health
education, community involvement [29], or outreach
program [36]), and case finding in the public and private
sector outside of DOTS program (via involvement of pri-
vate practitioners in suspected TB case referral [37], diag-
nosis, and treatment [30,38]) can be feasible and
effectively improve TB case finding.
Three strategies are hypothesized to potentially improve
TB detection and cure rates. Strategy A can be imple-
mented through symptom-based household contact
screening as conducted in Northern Lima, Peru [35]. An
example of intervention to achieve strategy B is the com-
munity outreach program in rural Southern Ethiopia [36],
where a TB campaign was conducted prior to a monthly
outreach visit to communities. Strategy C is exemplified
by the involvement of private providers, such as informal
village doctors in Bangladesh, to refer TB suspects to
DOTS facilities [37]. All these interventions lead to sub-
stantial improvement in TB case finding. However, the
feasibility of actually adopting the suggested intervention
strategies in Jogjakarta province remains to be seen. For
example, to refer all TB suspect patients to DOTS facilities
(strategy C) requires involvement of all private providers.
In reality, this may be impractical and difficult to achieve.
The feasibility and acceptability of an intervention is to a
large extent setting-specific. Any intervention program
should be assessed after consultation with local experts.
Still, explorations with the model can at least demonstrate
the most promising control options with regard to their
expected effectiveness.
Effectiveness of a disease intervention is commonly meas-
ured by averted disease burden in terms of disability
adjusted life years (DALY). In TB, 86% of healthy life lost
can be attributed to premature death, while only 14% is
due to illness [30]. The model shows that reducing the
number of never seeking care TB patients will have the
greatest impact on mortality, and will thus result in the
greatest improvement in DALY. Further, Borgdorff et al.
suggested that ACF would only have limited impact on
mortality if the intervention detects patients who would
otherwise have been detected through self-reporting [39].
Thus challenges remain in targeting specific high-risk TB
sub-groups, e.g. prison inmates, HIV patients, and urban
Sensitivity analysis: impact of changes of the transition rates  between the different model compartments on the predicted  percentage of partially cured and TB-related death Figure 3
Sensitivity analysis: impact of changes of the transi-
tion rates between the different model compart-
ments on the predicted percentage of partially cured 
and TB-related death. Grey dots represent the results 
using a transition rate of 2/3 times the baseline value, and 
black dots represent the results using a transition rate of 3/2 
times the baseline value. The two vertical black lines repre-
sent the respective baseline outcomes.BMC Infectious Diseases 2009, 9:87 http://www.biomedcentral.com/1471-2334/9/87
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slums dwellers, who have limited access to health services
and are less likely to seek care on their own.
The potential effectiveness of implementation strategies
should also be judged against the potential costs for
implementing such strategies. This is a particularly impor-
tant consideration in resource-constrained settings such as
Indonesia. In these settings, cheaper, albeit less effective,
interventions may be a more pragmatic option. Several
economic evaluation studies have assessed the cost effec-
tiveness of different TB control strategies, mainly related
to DOTS. However, only a limited number of economic
evaluations on case finding strategies are available,
mainly in the setting of developed countries
[30,32,40,41]. Further, no economic evaluation has been
published on community based case finding or interven-
tions to refer TB suspects from private providers to DOTS
facilities. A study in Dar es Salaam suggests that an active
case finding strategy may cost less than $276 US per case
treated (1996 exchange rate), in a situation where house-
hold cost is the main component of cost for tuberculosis
management [42]. The Indonesia NTP's marginal costs of
a case successfully treated for 2004–2005 is approximately
$450 US [1,43]. This suggests that the ACF strategy in
high-risk populations with limited access to DOTS facili-
ties could potentially be considered cost-effective in the
Indonesian context. Notwithstanding, formal cost effec-
tiveness analysis comparing ACF, community based case
finding, and intervention to refer TB suspects from private
providers to DOTS facilities (which is beyond the scope of
this study) clearly needs to be carried out before ACF can
be advocated as a priority policy option. Results of an eco-
nomic study of an intervention to refer TB suspects from
private providers to DOTS facilities in Jogjakarta province
is undergoing evaluation at the time of writing and is
expected to shed more light on this issue.
Our model development process has demonstrated signif-
icant gaps in knowledge. In general there is little data
about the TB diagnosis and treatment process and the out-
come in non-DOTS services. Also, little is known about TB
patients who never seek care and TB patients who enter
the alternative services sector. Another knowledge gap
exists regarding the sensitivity of health services in identi-
fying TB suspects. Further, there are limited evidences of
cost effectiveness of TB case finding implementation strat-
egies. Thus, further studies are needed to provide such evi-
dence.
Conclusion
We used mathematical modeling to explore the impact of
Indonesian health system interventions on tuberculosis
treatment outcome and deaths. We relied on expert opin-
ion to quantify the parameters. The fact that the model
output showed similar results to epidemiological data
suggests that the experts had an accurate understanding of
this subject, thereby reassuring the quality of our predic-
tions. The model highlighted the potential effectiveness of
active case finding of tuberculosis patients with limited
access to DOTS facilities in the developing country setting.
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